Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Peptides ; 69: 118-26, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25959537

ABSTRACT

Kinin B1 receptor (B1R) is virtually absent under physiological condition, yet it is highly expressed in models of diabetes mellitus. This study aims at determining: (1) whether B1R is induced in the brain of insulin-resistant rat through the oxidative stress; (2) the consequence of B1R activation on stereotypic nocifensive behavior; (3) the role of downstream putative mediators in B1R-induced behavioral activity. Sprague-Dawley rats were fed with 10% D-glucose in their drinking water or tap water (controls) for 4 or 12 weeks, combined either with a standard chow diet or a diet enriched with α-lipoic acid (1 g/kg feed) for 4 weeks. The distribution and density of brain B1R binding sites were assessed by autoradiography. Behavioral activity evoked by i.c.v. injection of the B1R agonist Sar-[D-Phe(8)]-des-Arg(9)-BK (10 µg) was measured before and after i.c.v. treatments with selective antagonists (10 µg) for kinin B1 (R-715, SSR240612), tachykinin NK1 (RP-67580) and glutamate NMDA (DL-AP5) receptors or with the inhibitor of NOS (L-NNA). Results showed significant increases of B1R binding sites in various brain areas of glucose-fed rats that could be prevented by the diet containing α-lipoic acid. The B1R agonist elicited head scratching, grooming, sniffing, rearing, digging, licking, face washing, wet dog shake, teeth chattering and biting in glucose-fed rats, which were absent after treatment with α-lipoic acid or antagonists/inhibitors. Data suggest that kinin B1R is upregulated by the oxidative stress in the brain of insulin-resistant rats and its activation causes stereotypic nocifensive behavior through the release of substance P, glutamate and NO.


Subject(s)
Diabetes Mellitus/genetics , Glutamic Acid/metabolism , Nitric Oxide/metabolism , Receptor, Bradykinin B1/metabolism , Substance P/metabolism , Animals , Binding Sites , Brain/metabolism , Brain/pathology , Diabetes Mellitus/metabolism , Diabetes Mellitus/pathology , Dioxoles/administration & dosage , Insulin/metabolism , Insulin Resistance/genetics , Insulin Resistance/physiology , Nitric Oxide/antagonists & inhibitors , Oxidative Stress , Rats , Receptor, Bradykinin B1/biosynthesis , Receptor, Bradykinin B1/genetics , Stereotyped Behavior/physiology , Substance P/antagonists & inhibitors , Sulfonamides/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL